CM
CM Management’s Nektar Therapeutics NKTR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Sell |
45,000
-755,000
| -94% | -$19.5M | 1.06% | 33 |
|
2025
Q1 | $544K | Buy |
800,000
+50,000
| +7% | +$34K | 0.55% | 44 |
|
2024
Q4 | $698K | Hold |
750,000
| – | – | 0.62% | 45 |
|
2024
Q3 | $975K | Hold |
750,000
| – | – | 0.78% | 46 |
|
2024
Q2 | $930K | Sell |
750,000
-189,847
| -20% | -$235K | 0.85% | 42 |
|
2024
Q1 | $878K | Hold |
939,847
| – | – | 0.74% | 45 |
|
2023
Q4 | $531K | Buy |
939,847
+139,847
| +17% | +$79K | 0.43% | 54 |
|
2023
Q3 | $476K | Buy |
800,000
+50,000
| +7% | +$29.8K | 0.51% | 48 |
|
2023
Q2 | $431K | Buy |
750,000
+350,000
| +88% | +$201K | 0.42% | 55 |
|
2023
Q1 | $281K | Buy |
400,000
+275,000
| +220% | +$193K | 0.33% | 54 |
|
2022
Q4 | $283K | Buy |
125,000
+75,000
| +150% | +$170K | 0.34% | 60 |
|
2022
Q3 | $160K | Sell |
50,000
-75,000
| -60% | -$240K | 0.18% | 71 |
|
2022
Q2 | $475K | Buy |
125,000
+50,000
| +67% | +$190K | 0.51% | 57 |
|
2022
Q1 | $404K | Buy |
75,000
+50,000
| +200% | +$269K | 0.34% | 69 |
|
2021
Q4 | $338K | Sell |
25,000
-25,000
| -50% | -$338K | 0.26% | 79 |
|
2021
Q3 | $898K | Hold |
50,000
| – | – | 0.67% | 56 |
|
2021
Q2 | $858K | Hold |
50,000
| – | – | 0.62% | 58 |
|
2021
Q1 | $1M | Buy |
50,000
+15,000
| +43% | +$300K | 0.74% | 57 |
|
2020
Q4 | $595K | Buy |
+35,000
| New | +$595K | 0.55% | 56 |
|